Pharmaceutical Technology, December 2011 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2011
Volume 35
Issue 12

Click the title above to open the Pharmaceutical Technology December 2011 issue in an interactive PDF format.

External Link - PharmTech_NA_Dec2011.pdf

Articles in this issue
i2-751280-1408612064577.gif
Global Healthcare on the Ground: USAID Works to Carry out President Obama's Global Health Initiative
i3-751298-1408612005414.gif
Contract API Manufacturing: The Year in Review
i1-751295-1408612018489.jpg
Troublesome Signs for Bio/Pharmaceutical R&D
Buzz Off the Product
PQRI Case Study (7): PackOut Remedies to Minimize Contamination and Exposure
PQRI Case Study (7): PackOut Remedies to Minimize Contamination and Exposure
Inside IPEC: IPEC Tackles Monographs, Impurities, Particles, and More
i4-751297-1408612011133.gif
FDA Revamps to Meet New Challenges
i3_t-751279-1408612067307.jpg
In the Spotlight December 2011
i1-751290-1408612037812.jpg
Auditing by the Numbers
Views from Pharma Leaders: A Year in Review and a Look Forward
Views from Pharma Leaders: A Year in Review and a Look Forward
i1-751289-1408612040257.jpg
Out-of-Specification Sample-Size Confusion
i1-751294-1408612020737.jpg
Supporting Innovation Requires Consistency and Vision
Report from Asia
Report from Asia
Q&A with Deborah Tanner, Covance
Q&A with Deborah Tanner, Covance
The Development of a Floating Drug-Delivery System for Metronidazole
The Development of a Floating Drug-Delivery System for Metronidazole
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney
June 30th 2025
Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

Close up the media plate on hand medical technicians working on bacterial culture and drug resistance of pathogens in laboratory. | Image Credit: © analysis121980 - stock.adobe.com

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

Patrick Lavery
June 26th 2025
Article

Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

Susan Haigney
June 25th 2025
Article

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Pharmacopoeia Goes Digital

Susan Haigney
June 25th 2025
Article

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.